About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
-Advanced
-Search Guidelines
Home
Advanced Search
Go to Top
Go to Top
Go to Bottom
Go to Bottom
4 results
1 of 1
1
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
Eryn Sara Rubenfeld, Michael Haim Dahan
Obstet Gynecol Sci.
2021;64(4):345-352. Published online 2021 June 9 DOI:
http://dx.doi.org/10.5468/ogs.21067
2
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Youngki Lee, Cheol Ryong Ku, Eui-Hyun Kim, Jae Won Hong, Eun Jig Lee, Sun Ho Kim
Endocrinol Metab.
2014;29(3):280-292. Published online 2014 September 25 DOI:
http://dx.doi.org/10.3803/EnM.2014.29.3.280
3
Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
Kyung Rae Cho, Kyung-Il Jo, Hyung Jin Shin
Brain Tumor Res Treat.
2013;1(2):71-77. Published online 2013 October 31 DOI:
http://dx.doi.org/10.14791/btrt.2013.1.2.71
4
Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
Eun-Hee Cho, Sang Ah Lee, Ji Youn Chung, Eun Hee Koh, Young Hyun Cho, Jeong Hoon Kim, Chang Jin Kim, Min-Seon Kim
J Korean Med Sci.
2009;24(5):874-878. Published online 2009 September 24 DOI:
http://dx.doi.org/10.3346/jkms.2009.24.5.874
1 of 1